Description
Product Description
Ingredients/Content
Active ingredients: Ingredients: MINOXIDIL 5%
Efficacy/Effectiveness
Minoxidil is also used to treat hair loss in addition to the first-line treatment of hypertension. It is effective in promoting hair growth in both men and women with male hormone alopecia. About 40% of men experience hair regrowth after 3-6 months.
Minoxidil must be used indefinitely to continue to support existing hair follicles and maintain experienced hair regrowth.
Oral minoxidil can cause side effects including swelling of the face and extremities, a fast and irregular heartbeat, and light head and heart problems.
Therefore, you should always consult your doctor or doctor before using this medicine.
Usage/Capacity
Spread 1ml twice a day in the morning and evening on the scalp. It varies from person to person, but you can check the effectiveness from about 8 weeks after using it.
Precautions for use
1. Do not administer it to the next patient.
1) Patients who are hypersensitivity to this drug or its components
2) a woman or child
3) a pregnant woman or a woman who may be pregnant
2. Carefully administer to the next patient.
a patient with liver dysfunction
Side effects
Symptoms of swelling of the face and extremities, a fast and irregular heartbeat, and a mild headache can occur.
If you feel any abnormalities, consult your doctor immediately.
Storage method
Store at room temperature (1-30℃), shielded airtight container
etc
Healing Pharma
Related products
-
Cenforce Professional 100mg (To melt under tongue) – 100 tablets
0 out of 5$60.00 – $107.00 Select options This product has multiple variants. The options may be chosen on the product page -
Dutasteride Veltride 0.5mg- 300 tablets
0 out of 5$128.00 Add to cart -
Finax 1mg (Finasteride FInax 1mg)- 300 tablets /600 tablets
0 out of 5$62.00 – $103.00 Select options This product has multiple variants. The options may be chosen on the product page -
Dutasteride Avosteride 0.5mg – 500 tablets
0 out of 5$67.00 Add to cart
Reviews
There are no reviews yet.